Cargando…
GCT-66. FINAL REPORT OF THE PROSPECTIVE NEXT/CNS-GCT-4 CONSORTIUM TRIAL (GemPOx FOLLOWED BY MARROW-ABLATIVE CHEMOTHERAPY) IN PATIENTS WITH REFRACTORY/RECURRENT CNS GERM CELL TUMORS
BACKGROUND: We report the responses, toxicities and long-term outcomes of gemcitabine, paclitaxel and oxaliplatin (GemPOx) regimen administered, in responsive patients, prior to single cycle marrow-ablative chemotherapy (thiotepa, etoposide and carboplatin) with autologous hematopoietic progenitor c...
Autores principales: | Shatara, Margaret, Blue, Megan, Stanek, Joseph R, Liu, Allison Y, Osorio, Diana S, AbdelBaki, Mohamed S, Prevedello, Daniel, Puduvalli, Vinay, Giglio, Pierre, Gardner, Sharon, Allen, Jeffrey, Wong, Kenneth E, Dhall, Girish, Finlay, Jonathan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715238/ http://dx.doi.org/10.1093/neuonc/noaa222.283 |
Ejemplares similares
-
GCT-40. PROGNOSTIC FACTORS FOR PATIENTS WITH RELAPSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)
por: Abu-Arja, Mohammad H, et al.
Publicado: (2020) -
GCT-74. RETROSPECTIVE LITERATURE REVIEW OF CENTRAL NERVOUS SYSTEM (CNS) GERM CELL TUMORS (GCTs) IN PATIENTS WITH DOWN SYNDROME (DS)
por: Harris, Micah K, et al.
Publicado: (2020) -
GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020) -
GCT-64. TREATMENT RESULTS IN CHILDREN WITH LOCALIZED CNS NGGCT
por: Vilesova, Irina, et al.
Publicado: (2020) -
GCT-20. EVALUATION OF NEURORADIOLOGICAL RESPONSE TO INDUCTION CHEMOTHERAPY FOR PATIENTS WITH LOCALISED GERMINOMA IN THE SIOP CNS GCT II TRIAL
por: Bison, Brigitte, et al.
Publicado: (2020)